Share Email Print
cover

Proceedings Paper

Results of treatment in patients with IIa - IIIast. breast cancer treated by combination of low-level laser therapy (LLLT) and surgery (5-year experience)
Author(s): V. A. Mikhailov; Oleg K. Skobelkin; I. N. Denisov; George A. Frank; N. N. Voltchenko
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Laser therapy with semiconductor laser (wavelength 890 nm) was performed in 41 patients with IIa - IIIast. breast cancer. LLLT was used before surgery and in postoperative period during 2 years. LLLT decreased postoperative complications by 15.3% and decreased duration of lymphorrhea. 5 years survival in patients with IIast. breast cancer treated by LLLT was 100%, in control group--85.71%. In patients with IIIast. breast cancer treated by LLLT survival was 94.44%, in control group--78.94%. 91.3% of patients with IIast. treated by LLLT had not recurrences in 5 year period, in the controls they were in about 77.7%. 82.35% of patients with IIIast. treated by laser therapy had no recurrences in 5 year period, in control group--60%.

Paper Details

Date Published: 8 January 1996
PDF: 9 pages
Proc. SPIE 2728, CIS Selected Papers: Laser Use in Oncology, (8 January 1996); doi: 10.1117/12.229474
Show Author Affiliations
V. A. Mikhailov, Ctr. of Laser Medicine (Russia)
Oleg K. Skobelkin, Ctr. of Laser Medicine (Russia)
I. N. Denisov, M.I. Setchenov Moscow Medical Academy (Russia)
George A. Frank, P.A. Hertzen Moscow Research Oncology Institute (Russia)
N. N. Voltchenko, P.A. Hertzen Moscow Research Oncology Institute (Russia)


Published in SPIE Proceedings Vol. 2728:
CIS Selected Papers: Laser Use in Oncology
Andrei V. Ivanov; Mishik A. Kazaryan, Editor(s)

© SPIE. Terms of Use
Back to Top